Trial intelligence / Profile preview

Eszopiclone on next day driving ability in insomnia

NCT00368056Phase 3Completed

Sponsor
Sumitomo Pharma America
Start
Apr 2005
Primary completion
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started Apr 2005; status: completed.

02

Drugs

eszopiclone
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00368056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00368056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call